Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comparative Analysis of Clinical Utility of Cytogenetics and Copy-Number-Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B-Cell Acute Lymphoblastic Leukemia.

Pediatric blood & cancer·2025
Same author

High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings.

Acta oncologica (Stockholm, Sweden)·2022
Same author

Molecular spectrum of inherited FVII deficiency in North India revealed a recurrent variant with a founder effect.

Haemophilia : the official journal of the World Federation of Hemophilia·2022
Same author

Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre study.

British journal of haematology·2022
Same author

Authors' response.

The Indian journal of medical research·2022
Same author

Bone marrow emboli following bone marrow procedure: A possible complication.

Indian journal of pathology & microbiology·2022

Related Experiment Video

Updated: May 10, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

Clozapine associated thrombocytopenia.

Natasha Kate1, Sandeep Grover, Munish Aggarwal

  • 1Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Journal of Pharmacology & Pharmacotherapeutics
|June 14, 2013
PubMed
Summary

Clozapine can cause a rare but serious side effect called thrombocytopenia, a low platelet count. Monitoring platelet levels is crucial for patients on clozapine, alongside white blood cell counts.

Keywords:
Clozapineplateletthrombocytopenia

Related Experiment Videos

Last Updated: May 10, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

Area of Science:

  • Pharmacology
  • Hematology
  • Psychiatry

Background:

  • Agranulocytosis is a known adverse effect of clozapine.
  • Data on clozapine-induced thrombocytopenia is limited.
  • Thrombocytopenia involves a reduction in platelet count.

Observation:

  • A 22-year-old female patient developed thrombocytopenia after 17 weeks of clozapine treatment (187.5 mg/day).
  • Thrombocytopenia persisted for 24 weeks despite dose reduction.
  • Discontinuation of clozapine led to the resolution of thrombocytopenia.

Findings:

  • Clozapine-induced thrombocytopenia is an under-recognized adverse effect.
  • This condition can be serious and requires clinical attention.
  • Platelet count monitoring is recommended for patients on clozapine.

Implications:

  • Clinicians should consider monitoring platelet counts in patients receiving clozapine.
  • Early detection and management of clozapine-induced thrombocytopenia are essential.
  • This case underscores the importance of comprehensive monitoring for clozapine side effects.